Literature DB >> 19545552

Binding of the monomeric form of C-reactive protein to enzymatically-modified low-density lipoprotein: effects of phosphoethanolamine.

Sanjay K Singh1, Madathilparambil V Suresh, David J Hammond, Antonio E Rusiñol, Lawrence A Potempa, Alok Agrawal.   

Abstract

BACKGROUND: The 5 subunits of native pentameric C-reactive protein (CRP) are dissociated to generate the monomeric form of CRP (mCRP) in some in vitro conditions, both physiological and non-physiological, and also in vivo. Many bioactivities of mCRP generated by urea-treatment of CRP and of mCRP generated by mutating the primary structure of CRP have been reported. The bioactivities of mCRP generated by spontaneous dissociation of CRP are largely unexplored.
METHODS: We purified mCRP generated by spontaneous dissociation of CRP and investigated the binding of mCRP to enzymatically-modified low-density lipoprotein (E-LDL).
RESULTS: mCRP was approximately 60 times more potent than CRP in binding to E-LDL. In the presence of the small-molecule compound phosphoethanolamine (PEt), at 37 degrees C, the binding of mCRP to E-LDL was enhanced <2-fold, while the binding of CRP to E-LDL was enhanced >10-fold. In contrast, PEt inhibited the binding of both CRP and mCRP to pneumococcal C-polysaccharide, another phosphocholine-containing ligand to which CRP and mCRP were found to bind. We have not investigated yet whether PEt alters the structure of CRP at 37 degrees C.
CONCLUSIONS: Combined data suggest that the targeting of CRP with the aim to monomerize CRP in vivo may be an effective approach to capture modified forms of LDL.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19545552      PMCID: PMC2739981          DOI: 10.1016/j.cca.2009.06.018

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  49 in total

1.  Expression, detection and assay of a neoantigen (Neo-CRP) associated with a free, human C-reactive protein subunit.

Authors:  L A Potempa; J N Siegel; B A Fiedel; R T Potempa; H Gewurz
Journal:  Mol Immunol       Date:  1987-05       Impact factor: 4.407

2.  C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance.

Authors:  Huijun Sun; Tomonari Koike; Tomonaga Ichikawa; Kinta Hatakeyama; Masashi Shiomi; Bo Zhang; Shuji Kitajima; Masatoshi Morimoto; Teruo Watanabe; Yujiro Asada; Yuqing E Chen; Jianglin Fan
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

3.  Immunohistochemical localization of modified C-reactive protein antigen in normal vascular tissue.

Authors:  E E Diehl; G K Haines; J A Radosevich; L A Potempa
Journal:  Am J Med Sci       Date:  2000-02       Impact factor: 2.378

4.  Membrane activity of a C-reactive protein.

Authors:  John M Harrington; Hui-Ting Chou; Thomas Gutsmann; Christoph Gelhaus; Henning Stahlberg; Matthias Leippe; Peter B Armstrong
Journal:  FEBS Lett       Date:  2009-02-21       Impact factor: 4.124

5.  Binding of C-reactive protein to modified low-density-lipoprotein particles: identification of cholesterol as a novel ligand for C-reactive protein.

Authors:  Sanna Taskinen; Petri T Kovanen; Hanna Jarva; Seppo Meri; Markku O Pentikäinen
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

Review 6.  The connection between C-reactive protein and atherosclerosis.

Authors:  Sanjay K Singh; Madathilparambil V Suresh; Bhavya Voleti; Alok Agrawal
Journal:  Ann Med       Date:  2008       Impact factor: 4.709

7.  Complement factor H binds to denatured rather than to native pentameric C-reactive protein.

Authors:  Svetlana Hakobyan; Claire L Harris; Carmen W van den Berg; Maria Carmen Fernandez-Alonso; Elena Goicoechea de Jorge; Santiago Rodriguez de Cordoba; German Rivas; Palma Mangione; Mark B Pepys; B Paul Morgan
Journal:  J Biol Chem       Date:  2008-09-11       Impact factor: 5.157

8.  Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia.

Authors:  Alexander Kovacs; Per Tornvall; Roland Nilsson; Jesper Tegnér; Anders Hamsten; Johan Björkegren
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-16       Impact factor: 11.205

9.  Elucidation of a protease-sensitive site involved in the binding of calcium to C-reactive protein.

Authors:  C M Kinoshita; S C Ying; T E Hugli; J N Siegel; L A Potempa; H Jiang; R A Houghten; H Gewurz
Journal:  Biochemistry       Date:  1989-12-12       Impact factor: 3.162

10.  C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas.

Authors:  G D Reynolds; R P Vance
Journal:  Arch Pathol Lab Med       Date:  1987-03       Impact factor: 5.534

View more
  7 in total

1.  C-reactive protein (CRP) aptamer binds to monomeric but not pentameric form of CRP.

Authors:  Min S Wang; Joshua C Black; Michelle K Knowles; Scott M Reed
Journal:  Anal Bioanal Chem       Date:  2011-07-02       Impact factor: 4.142

2.  Identification of acidic pH-dependent ligands of pentameric C-reactive protein.

Authors:  David J Hammond; Sanjay K Singh; James A Thompson; Bradley W Beeler; Antonio E Rusiñol; Michael K Pangburn; Lawrence A Potempa; Alok Agrawal
Journal:  J Biol Chem       Date:  2010-09-14       Impact factor: 5.157

3.  Direct visualization of electrophoretic mobility shift assays using nanoparticle-aptamer conjugates.

Authors:  Min S Wang; Scott M Reed
Journal:  Electrophoresis       Date:  2011-12-14       Impact factor: 3.535

4.  Structurally Altered, Not Wild-Type, Pentameric C-Reactive Protein Inhibits Formation of Amyloid-β Fibrils.

Authors:  Donald N Ngwa; Alok Agrawal
Journal:  J Immunol       Date:  2022-08-17       Impact factor: 5.426

5.  The binding of C-reactive protein, in the presence of phosphoethanolamine, to low-density lipoproteins is due to phosphoethanolamine-generated acidic pH.

Authors:  Sanjay K Singh; David J Hammond; Bradley W Beeler; Alok Agrawal
Journal:  Clin Chim Acta       Date:  2009-08-28       Impact factor: 3.786

6.  Probing the phosphocholine-binding site of human C-reactive protein by site-directed mutagenesis.

Authors:  A Agrawal; Y Xu; D Ansardi; K J Macon; J E Volanakis
Journal:  J Biol Chem       Date:  1992-12-15       Impact factor: 5.157

Review 7.  C-Reactive Protein: Friend or Foe? Phylogeny From Heavy Metals to Modified Lipoproteins and SARS-CoV-2.

Authors:  Michael Torzewski
Journal:  Front Cardiovasc Med       Date:  2022-03-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.